Oxford Nanopore, which markets the world’s only portable DNA sequencer, has reeled in $126 million through a private placement. This new funding brings the…

A collaborative effort has developed a synthetic viral genome for bone cancer research and may prove revolutionary in the battle against cancer overall.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.

Microbiome data is now part of Repositive’s Specialised Data Collections and offers researchers 21,000 data sets from human metagenomic studies.

Berg is applying its technology to breast cancer samples gathered by a Department of Defense program.

Bayer has adopted Phlexglobal’s electronic trial master file system across most of its clinical trials.

Dr. Patrick Soon-Shiong’s NantHealth and collaborators have begun a $20 million pediatric brain tumor sequencing project.

The FDA has awarded a computational science and bioinformatics contract worth up to $112 million to Engility.

Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration

Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.